Dr. Ifeyinwa (Ify) Osunkwo, MD, MPH is the chief patient officer for Novo Nordisk Rare Disease. She is an internationally acclaimed expert in sickle cell disease, a health literacy and equity advocate, and an expert in the management of chronic pain. In her role as rare D CPO Dr Osunkwo is responsible for realising Novo Nordisk’s vision to transform the lives of patients by improving access and care through partnerships with global patient and community stakeholders while driving an internal culture of patient-centric treatment solution development.
Dr. Ify Osunkwo spent 30 years as a lifespan haematologist, principal investigator and clinical trialist both in the US and Africa. A dual national of the US and Nigeria, Dr. Ify holds an MD from The University of Nigeria, an MPH from Johns Hopkins University, Baltimore MD (USA) and is board-certified in paediatric haematology and oncology.